Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329055 · ClinicalTrials.gov registry record
Events Before Death
A clinical trial of End Stage Renal Disease, sponsored by Renal Research Institute.
- Completed
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT01329055 is a study of End Stage Renal Disease that has completed, run by Renal Research Institute. The registered enrollment target is 50,000 participants, above the 252-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (19741% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01329055, a study of End Stage Renal Disease, has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous studies of the patients treated in RRI clinics suggest that hemodialysis patients undergo a certain consistent predictable pattern at the initiation of dialysis and before death. This pattern can be described as a group of patterns of patients' biological markers over a few months after starting dialysis and several months prior to death. Additional patterns can be observed that occur with changes in seasons or time of day. The aim of this study is to compare these patterns in patients treated in FMC-Asia, FMC-Europe, FMC-South America, and RRI-US populations. Noting that patterns in patient parameters are similar across continents, climates, and geographic variations only further accentuates the importance in the models that can predict patients' survival and provide an opportunity for timely intervention.
Conditions Studied
Study Locations (1)
New York
- Renal Research Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2000-01 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01329055
The ClinicalTrials.gov registry entry for NCT01329055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 252-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (19741% higher). The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01329055 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01329055 about?
NCT01329055 is a clinical study titled "Events Before Death". Previous studies of the patients treated in RRI clinics suggest that hemodialysis patients undergo a certain consistent predictable pattern at the initiation of dialysis and before death. This pattern can be described as a group of patterns of patients' biological markers over a few months after sta...
What is the current status of trial NCT01329055?
This trial is currently completed. The enrollment target is 50,000 participants. The study started on 2000-01. Estimated completion is 2010-05.
What conditions does trial NCT01329055 study?
This clinical trial studies the following conditions: End Stage Renal Disease.
Who is sponsoring clinical trial NCT01329055?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01329055 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RECRUITING
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RECRUITING · Phase 1
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.